Annual Meeting

Deepening research on oxygen’s role, with an eye on health

Paula Amann
March 14, 2023

When Julianty Frost was a child on Great Karimun Island in Indonesia, she attended school, though her parents never had. The absence of education in her family loomed large in her youth; two relatives died because the community lacked health information and proper medical care.

Between home and the classroom, Frost learned two dialects of Chinese — Hokkien and Teochew — along with the official Indonesian language and English, the lingua franca of global science. She picked up Mandarin from watching TV at home. “I grew up in five languages,” she said.

Julianty Frost
Julianty Frost

Frost, who recently served as a research associate in molecular and clinical cancer medicine at the University of Liverpool, developed a love of science at her postsecondary polytechnic school in Singapore, where she moved on her own when she was 14.

Frost won a 2022 J BC Herbert Tabor Early Career Investigator Award for research she did as a postdoctoral fellow in the laboratory of Alessio Ciulli, a professor of chemical and structural biology and director of the Centre for Targeted Protein Degradation at the University of Dundee in Scotland. A series of happy accidents led her to Scotland and then to England.

While earning her polytechnic diploma in Singapore, Frost enjoyed a final-year internship in Dublin. There one of her mentors had ties with the University of Dundee. Frost got the opportunity to attend the institution as a third-year undergraduate, and she seized it.

“It was challenging, but it worked out,” she said.

Frost dove into an honors project on the degradation of a hypoxia-inducible factor. She pursued graduate studies with Ciulli’s associate, Sonia Rocha, then a professor at Dundee and now executive dean of the new Institute of Systems, Molecular and Integrative Biology at the University of Liverpool.

“It was she who encouraged me to consider the path of the Ph.D.,” Frost said. “Sonia had an open door.”

Frost deferred receipt of her JBC Tabor award for a year because she was on maternity leave. As she charts her next career step, which she hopes will include the data analysis she loves, she hasn’t lost her sense of wonder.

“There’s just so much to discover,” she said. “Everything in the body, every molecule works to make us who we are.”

Specific inhibitors show treatment potential

Von Hippel–Lindau syndrome, or VHL, is a rare hereditary condition caused by a mutation in a single gene. The disorder is linked to cysts and tumors in multiple organs, such as the brain, spinal cord, eyes, kidney and pancreas.

Julianty Frost, Sonia Rocha and Alessio Ciulli worked together at the University of Dundee to characterize inhibitors of the VHL protein, a tumor suppressor that is part of a Cullin2 ligase complex. The team used mass spectrometry to pinpoint proteomic changes set off by the VHL inhibitor, compared with those caused by hypoxia or the enzyme inhibitor IOX2.                                                                          

In a result that surprised the research team, VHL inhibitors up-regulated VHL itself by means of protein stabilization of VHL isoforms. The study showed how specific VHL inhibitors can be and how their impact varies with the length of treatment. These findings suggest that use of VHL inhibitors may not produce overt side effects from stabilized hypoxia-inducible factor alpha, a transcription factor that plays a key role in the cell’s response to low oxygen.

The study zeroed in on the features of a small-molecule VHL inhibitor that Frost first examined in her doctoral thesis. This molecule “has the potential for chronic anemia treatment,” Frost said, noting that similar substances are now in clinical trials.

Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein” was published in the Journal of Biological Chemistry in August 2021. Frost and other winners of the JBC Tabor Award will give talks during a symposium on Sunday, March 26, at Discover BMB in Seattle.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Paula Amann

Paula Amann is a former ASBMB Today writer. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.